Lexaria Announces Second Production Facility and Vendor

New Post Public Reply Private Reply Replies (0) Message Board
Jerseyfish
Lexaria Announces Second Production Facility and Vendor Intention to Finance up to $3,000,000
Date : 05/27/2014 @ 8:20AM
Source : Access Wire
Stock : Lexaria Corp. (QB) (LXRP)
Quote : 0.319 0.049 (18.15%) @ 10:46AM

Lexaria Announces Second Production Facility and Vendor Intention to Finance up to $3,000,000
Print
Alert

Kelowna, BC / ACCESSWIRE / May 27, 2014 / Lexaria Corp. (LXRP-OTCQB) (LXX-CSE) (the "Company" or "Lexaria" announces it has entered a detailed Letter of Intent with Huntington Property Group Inc, an Ottawa-based real estate developer for its second marijuana production facility in Canada. As provided for in Letter of Intent, Lexaria also announces a financing intention of up to $3,000,000, including Vendor Financing, subject to certain terms and conditions as detailed in the Letter of Intent.

The facility is located in the Eastern Ontario area and is of a total potential area of over 80,000 sq ft; to be completed in an expected multi-phase development program. The first phase is to be over 20,000 sq ft. Lexaria will be the operator of this facility and would own 100% rights, with no overrides or royalties due to any party. Lexaria is issuing no shares whatsoever in order to acquire the rights to this facility.

No lease (rent) payments are scheduled to begin until such time as the municipality grants its approval of the building zoning for marijuana production purposes. Lexaria and the building owner are preparing an application to the municipality for such approval and based upon available information anticipate that such approval could be granted within 90 days. In the event the municipality does not for any reason approve the building for the purpose of medical marijuana production, Lexaria and the building owner have agreed to locate and use an alternate building.

Alan Whitten, President of Huntington Property Group Inc. says, “We are happy to get involved in this burgeoning sector. We believe in Lexaria’s growth plan and have confidence in their personnel to achieve their plans, and are pleased to commit to it. We look forward to a mutually beneficial long term relationship, as our investment indicates.”

Lexaria notes that this agreement for its second production facility was negotiated and entered only six weeks after its first production facility was announced, which was the 49%-owned joint venture with Enertopia Corp.

Lexaria will own 100% interest in the production facility by paying 100% of all initial and ongoing expenses related to the project. An initial 10-year lease will be entered, with options to renew the lease for an additional 16 years. The vendor is contributing up to $1,000,000 in cash payments directed toward the conversion costs required to renovate for the marijuana production facility, thus reducing Lexaria’s capex in the renovation costs.

Lexaria is also pleased to announce that a number of investors, including the building owner, have agreed in principle and subject to suitability and other conditions, to invest up to $2,000,000 into Lexaria, on terms in accordance with Canadian Securities Exchange and all regulatory requirements including required restricted periods. The intended investment would be part of the financing recently announced by Lexaria, and would be by Canadian accredited, non- US persons. Proceeds from this financing will be used to build out the Eastern Ontario facility for the purposes of medical marijuana production, and for general working capital. Lexaria cautions that the Letter of Intent is a preliminary step only and cannot provide any assurances that the Letter of Intent will result in a successfully closed acquisition or financing.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

Chris Bunka commented that “We are very pleased to enter the next phase of our growth initiative with the prestigious Huntington Property Group Inc. We intend to nurture this relationship for the benefit of all our shareholders. We share a common vision, and will also enjoy long term benefits as confirmed by their capital commitment.”

Lexaria believes that all stakeholders, including prospective customers, shareholders and others, are best served by Lexaria operating under more than a single Health Canada license under the MMPR. Multiple licenses protect shareholders and customers by adding redundancy to operations, and avoiding or mitigating loss in the event of unexpected production complications or any other unpredictable events.

Lexaria is now involved in two potential marijuana production facilities, both located in Ontario, each capable of significant expansion from Phase I initial buildout, and each large enough to offer significant cost efficiencies compared to smaller facilities.

The new facility in no way reduces Lexaria’s commitment to its previously announced greater Toronto area facility, which continues to advance separately. The Company looks forward to reporting additional developments on the advancement of this facility as they occur.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit http://www.lexariaenergy.com/.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Ken Faulkner, Institutional and Business Development: (250) 765-3630 Office
Clark Kent, Media Inquiries: (647) 519-2646

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors but they include and are not limited to the existence of underground deposits of commercial quantities of oil and gas; cessation or delays in exploration because of mechanical, weather, operating, financial or other problems; capital expenditures that are higher than anticipated; or exploration opportunities being fewer than currently anticipated. There can be no assurance that road or site conditions will be favorable for field work; no assurance that well treatments or workovers will have any effect on oil or gas production; no assurance that oil field interconnections will have any measurable impact on oil or gas production or on field operations, and no assurance that any expected new well(s) will be drilled or have any impact on the Company. There can be no assurance that expected oil and gas production will actually materialize; and thus no assurance that expected revenue will actually occur. There is no assurance the Company will have sufficient funds to drill additional wells, or to complete acquisitions or other business transactions. Such forward looking statements also include estimated cash flows, revenue and current and/or future rates of production of oil and natural gas, which can and will fluctuate for a variety of reasons; oil and gas reserve quantities produced by third parties; and intentions to participate in future exploration drilling. Adverse weather conditions including but not limited to surface flooding can delay operations, impact production, and cause reductions in revenue. The Company may not have sufficient expertise to thoroughly exploit its oil and gas properties. The Company may not have sufficient funding to thoroughly explore, drill or develop its properties. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company's public announcements and filings. There is no assurance that the medical marijuana business will provide any benefit to Lexaria, and no assurance that any proposed new facility will be built or proceed, nor that municipal or Health Canada regulatory approvals will be obtained. There is no assurance that the intended $2,000,000 investment by a number of investors, including the building owner, will in fact occur in whole or in part. There is no assurance that the first phase renovation project of approx. 20,000 sq ft will in fact be constructed, or that it will be constructed on time or budget. There is no assurance that the municipality where the building is located will grant its approval for a medical marijuana production facility.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.



Source: Lexaria Corp.
Lexaria Corp. (QB) (USOTC:LXRP)
Historical Stock Chart

1 Year : From May 2013 to May 2014
Click Here for more Lexaria Corp. (QB) Charts.
Lexaria Corp. (QB) (USOTC:LXRP)
Intraday Stock Chart

Today : Wednesday 28 May 2014
Click Here for more Lexaria Corp. (QB) Charts.

Bookmark With :
Facebook MySpace Twitter Digg Del.icio.us StumbleUpon Reddit Google Bookmarks Newsvine Technorati Furl AIM Slashdot Yahoo

Lexaria Bioscience Corp. (LXRPD) Stock Research Links

LXRPD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

4Roots Picks MSG for IT & Cybersecurity Support

Updated Category News Views 0

Tech-Boost for a Community Farm Vision Seems like everyone's buzzing about sustainability these days, and why not? It's the way forward. Take 4Roots and their Farm Campus initiative in Orlando. They've hooked up with Managed Services Group (MSG) to bolster their tech backbone, raising the stakes for their mission to shake up the food system. It's a no-nonsense...

Continue Reading
Better's 90-Day Plan: Growth Amidst Governance Gamble

Updated Category News Views 0

Unpacking the Ambitious 90-Day Plan When you hear Vishal Garg's name next to a 90-day sprint plan, it's not your everyday boardroom shuffle—you know there's grit behind the screen. Better Home & Finance (BETR) is angling for a massive turnaround with its latest rollout, but whether it's all sizzle and no steak is what we're here to figure out. Financial Metrics and...

Continue Reading
Photronics Investors Must Act by Sept. 4, 2026 Deadline

Updated Category News Views 0

Action Time for Photronics Investors There's nothing like a looming deadline to get the adrenaline pumping, especially when you're staring down the barrel of a federal securities class action. Photronics, Inc. (NASDAQ: PLAB) has found itself tangled in legal webs, with the clock ticking down to September 4, 2026. That’s the deadline for investors to move on being the...

Continue Reading
TELUS Digital Shakes Up Dreamforce with Exclusive Session

Updated Category News Views 17

What's Cooking at Hotel Zetta? Ever see a company shake up an event like TELUS Digital is about to at Dreamforce 2026? Instead of the usual booth schmooze-fest at Moscone Center, these folks are camping at Hotel Zetta with a packed 'boutique' agenda. From September 15–16, they're rolling out serious insider sessions for the big brains in financial services, education,...

Continue Reading
Wise Group Investors Alert Ahead of Key Legal Deadline

Updated Category News Views 0

Sizing Up the Legal Stakes for Wise Group Alright, here's a doozy that's bound to get your attention if you've got a stake in Wise Group plc (NASDAQ: WSE). We're talking about a looming securities class action, with the deadline to get involved barreling down like a runaway freight train. Before September 29, 2026, to be exact—mark it, circle it, do whatever you have to...

Continue Reading
PLAY Palm Angels Launches at Pacsun with Avani Gregg

Updated Category News Views 3

Revamping Streetwear with PLAY Palm Angels and Pacsun In a move that's making waves from the fashion runways straight into the heart of youth culture, PLAY Palm Angels is swooping into Pacsun, and they’re not just strolling in—they’re parading with a 41-piece fashion collection. Not to mention, they've snagged Avani Gregg, a powerhouse cultural influencer, to strut...

Continue Reading
Tahoe Truckee Life TV Series Elevates Local Flavor

Updated Category News Views 2

Meet “Tahoe Truckee Life” Kane Schaller, the face of the Tahoe Truckee Life series, is giving folks a front-row seat to the lives and landscapes that make the Reno-Tahoe region buzz. Now, I've seen shows trying to pull this off, but this one might just spark something genuine if done right. The Real Deal on Reno-Tahoe The show airs on the REAL Shows Network—a...

Continue Reading
Catholic Colleges Excel in AI Readiness, Study Shows

Updated Category News Views 3

Faith and Tech: An Unexpected Alliance? Alright, here's something that'll make you sit up: Catholic college grads are not just busy sipping their morning coffee while they muse over moral philosophy—they're out there on the front lines of artificial intelligence, better prepared and more engaged than their peers from secular schools. According to the latest Holistic...

Continue Reading
Médunik Canada Boosts Dravet Syndrome Support with Biocodex

Updated Category News Views 1

Breaking Down the Exclusive Médunik-Biocodex Partnership Listen, when a company like Médunik Canada, firmly rooted in Blainville, QC, throws its weight behind a rare disease drug like Diacomit®, folks in the industry take notice. Their recent handshake with Biocodex isn't just small talk; it opens doors to change how Dravet syndrome is managed across Canada. This new...

Continue Reading
EzCheckPrinting Boosts Remote Check Solutions Cost-Effectively

Updated Category News Views 1

Navigating the Check Printing Landscape Let's dive right into the changing realities of the workspace. With remote work becoming the new standard, small businesses are juggling tighter budgets while trying to maintain smooth financial operations. It's a hard game, but here is where Halfpricesoft.com rolls out their newly upgraded multi-user ezCheckPrinting software,...

Continue Reading

Top 5 Most Recently Viewed Articles

Uncovering Legal Options for MoonLake Immunotherapeutics Investors

Updated Category News Views 185

Overview of MoonLake Immunotherapeutics Class Action Investors in MoonLake Immunotherapeutics (NASDAQ: MLTX) have recently found themselves facing significant challenges. The disclosures regarding the company’s operations and the marketing of its products have prompted questions about the integrity of the information provided to shareholders. Why a Class Action? In a...

Continue Reading
BioCryst Sells European ORLADEYO Business for $250 Million

Updated Category News Views 184

BioCryst Concludes Successful Sale of European ORLADEYO Business In a significant move, BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has confirmed the successful sale of its European ORLADEYO business to Neopharmed Gentili. This transaction is valued at $250 million and includes the potential for up to $14 million in future milestones linked to sales across Central and...

Continue Reading
Investors of Edwards Lifesciences Urged to Seek Legal Counsel

Updated Category News Views 200

Overview of Investor Rights in the Edwards Lifesciences Case In today's financial landscape, safeguarding your investments is paramount. Edwards Lifesciences Corporation (NYSE: EW) has emerged as a notable player in the healthcare sector, particularly in innovative heart valve therapies. However, recent events have raised concerns among shareholders, prompting calls for...

Continue Reading
Accuray Unveils Innovative Radiotherapy Solution for Cancer Care

Updated Category News Views 174

Revolutionizing Radiotherapy with Accuray Stellar Accuray, a leader in adaptive radiotherapy, has launched the Accuray Stellar™ Solution, which is designed to transform cancer care. This innovative solution offers an expansive toolbox that empowers clinical teams to adapt treatments to fit each patient's unique needs. Accuray's commitment to enhancing radiotherapy...

Continue Reading
Scale Computing Shines on Prestigious AI 100 Awards List

Updated Category News Views 191

Scale Computing Shines on Prestigious AI 100 Awards List Scale Computing, the market leader in edge computing and hyperconverged solutions, has recently made waves in the tech industry by being recognized on the annual CRN AI 100 list. This list marks a milestone as it celebrates companies that are at the forefront of innovation in artificial intelligence. Understanding...

Continue Reading